177 related articles for article (PubMed ID: 7772617)
1. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
Maes M; Meltzer HY; Buckley P; Bosmans E
Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
[TBL] [Abstract][Full Text] [Related]
4. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
Maes M; Meltzer HY; Bosmans E
Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
[TBL] [Abstract][Full Text] [Related]
5. Indicators of immune activation in major depression.
Sluzewska A; Rybakowski J; Bosmans E; Sobieska M; Berghmans R; Maes M; Wiktorowicz K
Psychiatry Res; 1996 Oct; 64(3):161-7. PubMed ID: 8944394
[TBL] [Abstract][Full Text] [Related]
6. Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.
O'Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd A; Wakefield D; McConaghy N
Psychiatry Res; 1996 Dec; 65(3):171-8. PubMed ID: 9029665
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
8. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Maes M; Meltzer HY; Bosmans E
Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
[TBL] [Abstract][Full Text] [Related]
9. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
10. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.
Maes M; Bosmans E; Ranjan R; Vandoolaeghe E; Meltzer HY; De Ley M; Berghmans R; Stans G; Desnyder R
Schizophr Res; 1996 Jul; 21(1):39-50. PubMed ID: 8998275
[TBL] [Abstract][Full Text] [Related]
11. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
Rapaport MH; Lohr JB
Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
[TBL] [Abstract][Full Text] [Related]
12. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production.
Maes M; Bosmans E; Suy E; Vandervorst C; DeJonckheere C; Raus J
Acta Psychiatr Scand; 1991 Oct; 84(4):379-86. PubMed ID: 1746291
[TBL] [Abstract][Full Text] [Related]
13. In vivo immunomodulatory effects of clozapine in schizophrenia.
Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
[TBL] [Abstract][Full Text] [Related]
14. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.
Maes M; Bosmans E; Meltzer HY
Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):172-8. PubMed ID: 7669825
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia.
Rapaport MH; Stein MB
Anxiety; 1994; 1(2):50-3. PubMed ID: 9160548
[TBL] [Abstract][Full Text] [Related]
16. Increased serum interleukin-1-receptor-antagonist concentrations in major depression.
Maes M; Vandoolaeghe E; Ranjan R; Bosmans E; Bergmans R; Desnyder R
J Affect Disord; 1995 Dec; 36(1-2):29-36. PubMed ID: 8988262
[TBL] [Abstract][Full Text] [Related]
17. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation.
Al-Hakeim HK; Al-Rammahi DA; Al-Dujaili AH
J Affect Disord; 2015 Aug; 182():106-14. PubMed ID: 25985379
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin 2 receptor levels in acute and stable schizophrenia.
Gaughran F; O'Neill E; Sham P; Daly RJ; Shanahan F
Schizophr Res; 2001 Oct; 52(1-2):143-4. PubMed ID: 11595403
[No Abstract] [Full Text] [Related]
19. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.
Katila H; Appelberg B; Hurme M; Rimón R
Schizophr Res; 1994 Apr; 12(1):29-34. PubMed ID: 8018583
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
